Vir Biotechnology (VIR) Gross Profit (2020 - 2025)

Vir Biotechnology's Gross Profit history spans 6 years, with the latest figure at $1.2 million for Q2 2025.

  • On a quarterly basis, Gross Profit fell 60.21% to $1.2 million in Q2 2025 year-over-year; TTM through Jun 2025 was $18.3 million, a 75.08% decrease, with the full-year FY2025 number at $68.5 million, down 6.58% from a year prior.
  • Gross Profit hit $1.2 million in Q2 2025 for Vir Biotechnology, down from $3.0 million in the prior quarter.
  • Over the last five years, Gross Profit for VIR hit a ceiling of $1.1 billion in Q1 2022 and a floor of $1.2 million in Q2 2025.
  • Historically, Gross Profit has averaged $151.5 million across 5 years, with a median of $14.3 million in 2022.
  • Biggest five-year swings in Gross Profit: skyrocketed 57709.21% in 2022 and later tumbled 99.26% in 2023.
  • Tracing VIR's Gross Profit over 5 years: stood at $755.9 million in 2021, then plummeted by 94.26% to $43.4 million in 2022, then crashed by 63.17% to $16.0 million in 2023, then fell by 26.89% to $11.7 million in 2024, then crashed by 89.71% to $1.2 million in 2025.
  • Business Quant data shows Gross Profit for VIR at $1.2 million in Q2 2025, $3.0 million in Q1 2025, and $11.7 million in Q4 2024.